Company intelligence / Profile preview

TPG Capital

United States

Ownership: Private
Development stage: Other

Overview

TPG Capital (part of TPG Inc.) is a global alternative asset manager and private equity firm that includes large healthcare- and life-science–focused investment platforms, but it is not itself a drug developer and has no therapeutic pipeline.[6][8][11]

Industry: Investors

Partnerships

Partnership with AmerisourceBergen to acquire OneOncology[8]Co‑investment with Leonard Green & Partners in WellSky[8]

Beyond the preview

Go deeper on TPG Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPG Capital.

Explore the full profile